BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35247089)

  • 21. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
    Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA
    JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
    Fasola G; Belvedere O; Aita M; Zanin T; Follador A; Cassetti P; Meduri S; De Pangher V; Pignata G; Rosolen V; Barbone F; Grossi F
    Oncologist; 2007 Oct; 12(10):1215-24. PubMed ID: 17962615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and Rationale of the HANSE Study: A Holistic German Lung Cancer Screening Trial Using Low-Dose Computed Tomography.
    Vogel-Claussen J; Lasch F; Bollmann BA; May K; Kuhlmann A; Schmid-Bindert G; Kaaks R; Barkhausen J; Bohnet S; Reck M
    Rofo; 2022 Dec; 194(12):1333-1345. PubMed ID: 35917826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of low-dose computed tomography in lung cancer screening].
    Ágh T; Szilberhorn L; Csanádi M; Széles G; Vokó Z; Ádám G; Kallai Á
    Orv Hetil; 2022 Sep; 163(37):1464-1471. PubMed ID: 36088623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary Nodules, Lung Cancer Screening, and Lung Cancer in the Medicare Population.
    Pinsky P; Miller E; Faris N; Osarogiagbon R
    Chest; 2023 May; 163(5):1304-1313. PubMed ID: 36529155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
    Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A;
    Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants].
    Tang W; Wu N; Huang Y; Wang J; Zhao S; Xu Z; Zhang K; Jiang Y; Cai Q; Zhou L; Li M; Tao D; Liu X; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):549-54. PubMed ID: 25327664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning.
    Ashraf H; Dirksen A; Loft A; Bertelsen AK; Bach KS; Hansen H; Pedersen JH; Mortensen J
    Thorax; 2011 Apr; 66(4):315-9. PubMed ID: 21169285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of the optimum definition of growth evaluation for indeterminate pulmonary nodules detected in lung cancer screening.
    Lee JH; Hwang EJ; Lim WH; Goo JM
    PLoS One; 2022; 17(9):e0274583. PubMed ID: 36108077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study.
    Veronesi G; Maisonneuve P; Bellomi M; Rampinelli C; Durli I; Bertolotti R; Spaggiari L
    Ann Intern Med; 2012 Dec; 157(11):776-84. PubMed ID: 23208167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk factors for lung cancer based on low-dose computed tomography screening].
    Jin YJ; Tang W; Huang Y; Wang JW; Hou DH; Qi LL; Zhao SJ; Wu N
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):222-227. PubMed ID: 32252201
    [No Abstract]   [Full Text] [Related]  

  • 32. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Protocol for Korean Lung Cancer Screening Project (K-LUCAS) to Evaluate Effectiveness and Feasibility to Implement National Cancer Screening Program.
    Lee J; Lim J; Kim Y; Kim HY; Goo JM; Lee CT; Jang SH; Lee WC; Lee CW; An JY; Ko KD; Lee MK; Choi KS; Park B; Lee DH
    Cancer Res Treat; 2019 Oct; 51(4):1285-1294. PubMed ID: 30776882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes.
    Triphuridet N; Vidhyarkorn S; Worakitsitisatorn A; Sricharunrat T; Teerayathanakul N; Auewarakul C; Chungklay N; Krongthong W; Luengingkasoot S; Sornsamdang G; Patumanond J; Sritipsukho P
    Lung Cancer; 2018 Aug; 122():243-248. PubMed ID: 30032839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A strategy to reduce the false-positive rate after low-dose computed tomography in lung cancer screening: A multicenter prospective cohort study.
    Wu Z; Tan F; Xie Y; Tang W; Wang F; Xu Y; Cao W; Qin C; Dong X; Zheng Y; Luo Z; Wang C; Zhao L; Xia C; Li J; Li R; Feng F; Li J; Ren J; Shi J; Cui H; Shen S; Wu N; Chen W; Li N; He J
    Cancer Med; 2023 Jul; 12(13):14781-14793. PubMed ID: 37199391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening.
    Kim YW; Kwon BS; Lim SY; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Chung JH; Ji E; Lee CT
    Thorax; 2021 Oct; 76(10):980-988. PubMed ID: 33859050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience.
    de-Torres JP; Alcaide AB; Campo A; Zulueta JJ; Bastarrika G; Ezponda A; Mesa M; Murillo D; Rodriguez M; Del Mar Ocón M; Felgueroso C; Pueyo J; Lozano MD; Montuenga LM; Berto J; Perez-Warnisher MT; Di-Frisco IM; Seijo LM
    Arch Bronconeumol; 2024 Feb; 60(2):95-100. PubMed ID: 38216404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can we increase efficiency of CT lung cancer screening by combining with CVD and COPD screening? Results of an early economic evaluation.
    Behr CM; Koffijberg H; Degeling K; Vliegenthart R; IJzerman MJ
    Eur Radiol; 2022 May; 32(5):3067-3075. PubMed ID: 34973103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
    Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
    Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
    Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.